HRMY
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Harmony Biosciences received FDA approval for WAKIX to treat cataplexy in pediatric narcolepsyFeb 17, 2026
- Harmony Biosciences announced positive results from pivotal bioequivalence study for pitolisant gastro-resistant formulationNov 24, 2025
- Harmony Biosciences announced initiation of first-in-human study with potentially best-in-class Orexin 2 receptor agonist (BP1.15205) for central disorders of hypersomnolenceNov 19, 2025
- Harmony Biosciences provides update from its Phase 3 RECONNECT study of ZYN002 in Fragile X SyndromeSep 24, 2025
- Harmony Biosciences presents preclinical data showing BP1.15205 enhances wakefulness and reduces cataplexy in narcolepsyJun 11, 2025